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Abstract: Cratoxylum arborescens is an equatorial plant belonging to the family Guttiferae. 
In the current study, α-Mangostin (AM) was isolated and its cell death mechanism was studied. 
HCS was undertaken to detect the nuclear condensation, mitochondrial membrane potential, 
cell permeability, and the release of cytochrome c. An investigation for reactive oxygen species 
formation was conducted using fluorescent analysis. To determine the mechanism of cell death, 
human apoptosis proteome profiler assay was conducted. In addition, using immunofluorescence 
and immunoblotting, the levels of Bcl-2-associated X protein (Bax) and B-cell lymphoma (Bcl)-2 
proteins were also tested. Caspaces such as 3/7, 8, and 9 were assessed during treatment. Using 
HCS and Western blot, the contribution of nuclear factor kappa-B (NF-κB) was investigated. AM 
had showed a selective cytotoxicity toward the cancer cells with no toxicity toward the normal 
cells even at 30 µg/mL, thereby indicating that AM has the attributes to induce cell death in tumor 
cells. The treatment of MCF-7 cells with AM prompted apoptosis with cell death-transducing 
signals. This regulated the mitochondrial membrane potential by down-regulation of Bcl-2 and 
up-regulation of Bax, thereby causing the release of cytochrome c from the mitochondria into 
the cytosol. The liberation of cytochrome c activated caspace-9, which, in turn, activated the 
downstream executioner caspace-3/7 with the cleaved poly (ADP-ribose) polymerase protein, 
thereby leading to apoptotic alterations. Increase of caspace 8 had showed the involvement of 
an extrinsic pathway. This type of apoptosis was suggested to occur through both extrinsic and 
intrinsic pathways and prevention of translocation of NF-κB from the cytoplasm to the nucleus. 
Our results revealed AM prompt apoptosis of MCF-7 cells through NF-κB, Bax/Bcl-2 and heat 
shock protein 70 modulation with the contribution of caspaces. Moreover, ingestion of AM at 
(30 and 60 mg/kg) significantly reduced tumor size in an animal model of breast cancer. Our 
results suggest that AM is a potentially useful agent for the treatment of breast cancer.
Keywords: α-Mangostin, apoptosis, mitochondria, protein array, caspace 3/7, NF-κB
Introduction
Breast cancer is one of the most deadly cancers affecting women worldwide because 
of its high rate of incidence and mortality. According to the American Cancer Society, 
breast cancer is emphasized to account for 26% of all new cancer cases, which is the 
highest in percentage among all the cancers in American women.1 In Malaysia, the 
National Cancer Registry reported that one in 20 Malaysian women are at a risk of 
acquiring breast cancer in their lifetime.2 This incidence rate is still considered low 
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compared to one in eight women in Europe and the United 
States.3 The causes, due to which up to 70% of breast cancer 
development occurs in women, are reported to be of envi-
ronmental factors and lifestyle. The remaining 30% may be 
attributed to genetic factors.4,5
Among the cancer treatment strategies, use of radiation 
therapy became a valuable tool for the control of local and 
regional diseases after 1960 with the invention of the linear 
accelerator, but, like surgery, radiation therapy alone could 
not enucleate metastatic cancer. Nevertheless, the success 
of the treatment depends on the capacity to reach every 
organ in the body of patients. Drugs, biological molecules, 
and immune-mediated remedies have therefore become the 
focus in the current efforts to cure cancer. Chemotherapy is 
defined as a mode of treatment in which drugs are used to 
retard or destroy the growth of malignant cells. These drugs 
are either used alone or in combination with one or more other 
drugs. For many years, tamoxifen has been considered as the 
drug of choice for the cure of estrogen-dependent cases. The 
antitumor effect of tamoxifen is due to the arrest of growth 
and prompting apoptosis,6 which is mediated by linkage to 
the intracellular estrogen receptor on the breast cancer cells, 
blocking of steroid hormone action,7 inhibition of protein 
kinase C8 and its binding to calmodulin.9
However, there are various side effects like develop-
ment of liver cancer, increased blood clotting, retinopathy, 
and corneal opacities when performing chemotherapy with 
tamoxifen.10 Due to these side effects, the use of herbs as an 
alternative therapy has attracted a great deal of interest by 
virtue of the lower toxicity and cost benefits.11 Many clinical 
attempts using herbs or natural products are being conducted 
around the world.12 Furthermore, some herbs and their con-
stituents have been reported to suppress the proliferation of 
cancer cells directly. Thus, the use of herbs could be a more 
effective strategy in the cure of cancer.13
Cratoxylum arborescens (C. arborescens) Blume is a 
traditional herb belonging to the Guttiferae family, and its 
natural range of distribution includes Malaysia, South Burma, 
Sumatra, and Borneo.14 This plant is used traditionally as a 
cure for fever, cough, diarrhea, and other ailments.15 The 
phytochemicals found in C. arborescens include a pharma-
cologically superior class of phytochemicals, xanthones.14,16 
α-Mangostin (AM) (Figure 1A) is one of the major xanthones 
extracted from the stem bark of this plant.17 AM possesses a 
wide spectrum of biological activities, which includes anti-
inflammatory,18,19 cardioprotective,20 antitumor,21,22 anti-
diabetic,23 antibacterial,24 antifungal,25 antioxidant,18,26 
anti-parasitic,27 and anti-obesity28 properties.
In this study, we evaluated the apoptotic cell death 
mechanism prompted by AM on breast cancer using MCF-7 
cells as an in vitro model. In addition to that, we investigated 
the antitumor activity of AM in the animal model.
Materials and methods
Cell culture
Normal breast cells, MCF-10 A, and MCF-7 cells, were 
acquired from the American Type Culture Collection 
( Manassas, VA, USA) and then kept at 37°C in an incubator 
with 5% CO
2
 saturation. They were grown in Roswell Park 
Memorial Institute medium (RPMI)-1640 (PAA Laboratories 
GmbH, Coelbe, Germany) together with 10% Fetal Bovine 
Serum (FBS).
Anti-proliferative effect  
of AM on MCF-7 cells
The inhibitory effect of AM was determined by MTT assay, 
in which 1×105 of MCF-7 cells/µL were seeded in triplicate 
in 96-well plates and kept for 24 hours at 37°C with 5% CO
2
 
saturation. After 24 hours’ incubation, a serial dilution for dif-
ferent concentrations of AM was prepared and transferred to 
the MCF-7 cells and incubated for 24 hours in 37°C and 5% 
CO
2
; 20 µL of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltet-
razolium bromide (MTT solution, 5 mg/mL) was added to the 
treated cells in a dark place, covered with foil, and incubated 
for 4 hours. All media were discharged and a total of 100 µL 
volume of dimethyl sulfoxide was poured into each well until 
the purple formazan crystals dissolved. The plate was mea-
sured using a microplate reader (Tecan Group Ltd.,  Männedorf, 
Switzerland) at absorbance 570 nm. The experiment was 
conducted in triplicate to evaluate half-maximal inhibitory 
concentration for AM against the MCF-7 cell line.
Acridine orange propidium  
iodide double staining using  
fluorescent microscopy
MCF-7 cells were quantified using acridine orange (AO) and 
propidium iodide (PI) double-staining in conformity with 
the standard procedures, and inspected under a fluorescence 
microscope (Leica [Leica Microsystems, Wetzlar, Germany] 
with Q-Floro Software [Leica Microsystems]). Concisely, the 
treatment was conducted in a 25 mL culture flask, in which 
1×105 MCF-7 cells/mL were seeded and treated with different 
concentrations of AM (5, 10, and 20 mg/mL) for 24 hours. After 
24 hours, the cells were centrifuged at 1,800 rpm for 5 minutes 
to discharge the old medium; then a cool PBS was used to wash 
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α-Mangostin demonstrates apoptogenesis in MCF-7 cells
the cells two times before staining with AO/PI. Equal amounts, 
10 µL (10 µg/mL), of fresh AO and PI were prepared and covered 
from light to stain the cell onto a glass slide, which was covered 
with a cover slip. The slides were viewed under a fluorescence 
microscope 30 minutes prior to the fluorescence fading.
Assay of the apoptotic rate  
by Annexin V (AV)-fluorescein 
isothiocyanate (FITC) staining
MCF-7 at concentration (1×105 cells/mL) was exposed to 5, 
10, and 20 µg/mL concentrations of AM, and the AV assay 
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Figure 1 Chemical structure of α-Mangostin (A). Fluorescent micrographs of AO and PI double-stained MCF-7 cells; (B) untreated cells showed normal structure without 
prominent apoptosis and necrosis; (C) early apoptosis features were seen after treatment with 5 µg/mL representing intercalated acridine orange (bright green) amongst the 
fragmented DNA; (D) blebbing and orange color representing the hallmark of late apoptosis were noticed in 10 µg/mL treatment; (E) bright red color secondary necrosis 
were visible after treatment with 20 µg/mL; (F) percentages of viable, early apoptotic, late apoptosis and secondary necrotic cells after AM treatment. MCF-7 cell death via 
apoptosis increased significantly (*P,0.05) in a concentration-dependent manner. However, no significant (P.0.05) difference was observed in the cell count of necrosis. 
Abbreviations: AM, α-Mangostin; AO, acridine orange; PI, propidium iodide; VI, viable cells; CC, chromatin condensation; LA, late apoptosis; EA, early apoptosis; SN, 
secondary necrosis.
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was executed with the use of the BD Pharmingen™ Annexin 
V-FITC Apoptosis Detection Kit (APO Alert Annexin V, 
Clontech, Mountain View, CA, USA). The treated cells 
were centrifuged for 5 minutes at 1,800 rpm to eliminate 
the media. Subsequently, cells were washed with 1× bind-
ing buffer provided by the manufacturer. Then the cells were 
re-suspended in 200 µL of binding buffer; 5 µL of AV, and 
10 µL of PI (Sigma-Aldrich Co, St Louis, MO, USA) were 
added before incubating at 37°C in the dark for 15 minutes. 
The binding buffer raised the reaction volume to 500 µL 
for the flow cytometric analysis. Flow cytometric analysis 
was conducted using FACS Canto II, (BD Biosciences, San 
Jose, CA, USA) cytometry b. The dimethyl sulfoxide-treated 
(0.1%, v/v) cells were employed as the control.
Nuclear morphology, membrane 
permeability, mitochondrial 
membrane potential ∆ψm (MMP), 
and cytochrome c release analysis
A Cellomics Multiparameter Cytotoxicity 3 Kit (Thermo 
Fisher Scientific, Waltham, MA, USA) was employed as 
previously described at length.29 The kit facilitates concur-
rent measurements of six independent parameters at the same 
time for the same cell population. Chromatin condensation, 
morphological change, detection of the MMP, release of 
cytochrome c, and cell permeability were used to test the 
loss of the MCF-7 cells. MCF-7 (1×105 cells/mL) were used 
to seed in 96 wells (Genetix Biotech Asia Pvt. Ltd., New 
Delhi, India) and treated with AM (5, 10, and 20 mg/mL). 
After 24 hours, the plates were processed according to the 
manufacturer’s instructions, and analyzed using the Array-
Scan HCS system (Thermo Fisher Scientific). The images and 
the intensity data were reading the texture of the fluorescence 
inside each of the cells, together with the typical fluorescence 
of the cell population inside the well. The experiment was 
done in triplicate.
Immunofluorescence  
analysis of Bax/Bcl-2
A total of 5×103 MCF-7 cells were seeded in a 96 well plate 
(genetix), followed by 5, 10, and 20 µg/mL of AM treatment. 
Then, the cells were fixed for 15 minutes at 37°C by 4% 
paraformaldehyde after rinsing two times with PBS. PBS was 
used to rinse the cells three times, the cells were treated using 
a blocking buffer for 60 minutes incubation in 0.03% Triton 
X-100/PBS (Sigma-Aldrich, St Louis, MO, USA) and normal 
serum before the cells were rinsed once more with PBS. The 
diluted primary antibody solution containing 1× PBS/1% 
BSA/0.3% Triton X-100, was added after the aspirate 
blocking buffer. The cells underwent incubation overnight 
at 4°C. B-cell lymphoma (Bcl)-2 and Bcl-2-associated X 
protein (Bax) fluorochrome-conjugated secondary antibody 
diluted (Santa Cruz Biotechnology Inc., Dallas, TX, USA) 
in antibody dilution or in PBS only was added to the cells 
and incubated for 1 hour. After rinsing three times in PBS, 
the cells were treated with DAPI and examined using the 
CellReporter™ cytofluorimeter system (Molecular Devices 
LLC, Sunnyvale, CA, USA).
Bioluminescent assay  
of caspaces 3/7, 8, and 9
A concentration-dependent study of the activity of cas-
pace-3/7, 8, and 9 was done using luminescence-based assay, 
Caspace-Glo™ 3/7, Caspace-Glo™ 8, and Caspace-Glo™ 
9 Assay (Promega Corporation, Fitchburg, WI, USA). The 
cells were seeded in 96-well plates in 50 µL of RPMI 1640 
together with 10% FBS and incubated for 24 hours. Then, the 
cells were treated with AM 5, 10, and 20 µg/mL and incubated 
for 24 hours at 37°C with 5% CO
2
. After 24 hours, 100 µL 
of the assay reagent was added and the plate was incubated 
for 1 hour at 37°C. Luminescence was calculated using a 
Tecan Infinite®200 Pro (Tecan, Männedorf, Switzerland) 
microplate reader.
Western blot analysis
MCF-7 cells were cultured in a 25 mL flask (TPP Techno 
Plastic Products AG, Trasadingen, Switzerland) and 
treated with AM 5, 10, and 20 µg/mL. The cells were col-
lected, washed by cool PBS, and mixed with a lysis buffer 
(50 mM Tris-Hcl pH 8.0, 120 mM NaCl, 0.5% NP-40, 1 
mM phenylmethylsulfonyl fluoride) to isolate the total 
proteins from the cells. A 40 µg measure of the extracted 
protein was separated using 12% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis, then moved to a polyvi-
nylidene difluoride membrane (Bio-Rad Laboratories Inc., 
Hercules, CA, USA), and blocked with 5% non-fat milk in 
a TBS-Tween buffer 7 (0.12 M Tris-base, 1.5 M NaCl, 0.1% 
Tween 20) for 30 minutes at room temperature, and incu-
bated with the appropriate primary antibody overnight at 
4°C, then incubated with alkaline phosphatase-conjugated 
secondary antibody for 30 minutes at room temperature, 
and then washed in Tris-buffered saline and Tween 20 
buffer. The primary antibodies, β-actin (sc-130300), Bax 
(sc-20067), heat shock protein (Hsp)70 (sc-69705), pro-
liferating cell nuclear antigen (PCNA) (sc-25280), Nf-κB/
P65 (sc-398442), cytochrome c (sc-13560), caspace-7 (sc-
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81660), caspace-8 (sc-81657), and caspace-9 (sc-56073) 
were purchased from Santa Cruz Biotechnology Inc., but 
Bcl2 (ab38629) and poly (ADP-ribose) polymerase (PARP) 
(ab4830) were purchased from Abcam plc (Cambridge, 
UK). The membranes were then incubated for 1 hour at 
room temperature with alkaline phosphatase conjugated 
goat anti-mouse or goat anti-rabbit secondary antibodies 
in a ratio of 1:5,000 and then washed twice with TBST 
for 10 minutes three times on an orbital shaker. Then, the 
blots were developed using the BCIP/NBT (Santa Cruz 
Biotechnology Inc.) for sensitive colorimetric detection 
to quantify the target protein band.
Determination of the intracellular 
reactive oxygen species (ROS) level
ROS was determined with 2′,7′-dichlorofluorescin diacetate 
(DCFH-DA).30–32 Concisely, 10 mM DCFH-DA stock solu-
tion (in methanol) was diluted 500-fold in Hank’s Balanced 
Salt Solution with no serum or further additives to yield a 
20 µM working solution. After exposure to AM for 24 hours 
the cells in the 96-well black plate were rinsed two times with 
Hank’s Balanced Salt Solution before incubating in a 100 µL 
working solution of DCFH-DA at 37°C for 30 minutes. 
Using a fluorescence microplate reader, Tecan Infinite®200 
Pro, the result was taken in emission at 485-nm excitation 
and 520-nm emission.
DNA content and cell cycle  
phase distribution
MCF-7 cells at a concentration of 1×105 cells/mL were 
seeded into a 25 mL flask containing RPMI 1640 augmented 
with 10% FBS and dosed with AM 5, 10, and 20 µg/mL. 
After incubation for 24 hours, the cells were collected, cen-
trifuged to remove the old medium, and washed two times 
using warm PBS, then the pellet was fixed with 90% cool 
ethanol (kept at -20°C for 1 day before use) and kept at 4°C 
overnight. After incubation, the cells were spun down for 
5 minutes at 1,800 rpm, the ethanol was removed and the 
pellets were washed with PBS to clear ethanol from the fixed 
cells. An amount of 600 µL warmed PBS was added and 
mixed gently. Then, 25 µL RNase A in a concentration of 
10 µg/mL and 50 µL of PI at a concentration 1 µg/mL were 
decanted into the pellet and preserved in a dark place for 
30 minutes. The DNA content of the cells was then examined 
using a FACS Canto II Becton-Dickinson Flow cytometer by 
studying at least 10,000 cells per sample. The percentage of 
cells in the G
1
, S, and G
2
 phases was investigated using Diva 
software (BD Biosciences, San Jose, CA, USA).
Immunofluorescence  
of NF-κB activity
HCS was utilized to assess the inhibitory effects of AM 
on tumor necrosis factor alpha (TNF-α)-induced NF-κB 
activation, ie, nuclear translocation of NF-κB. The 
experiments were conducted according to the company’s 
instructions for the NF-κB activation kit (Thermo Fisher 
Scientific). An ArrayScan reader was utilized to measure the 
variance between the strength of the nuclear and cytoplasmic 
NF-κB-associated fluorescence, and reported as a transloca-
tion parameter.
Human apoptosis proteome  
profiler array
To examine the pathways through which AM prompts apop-
tosis, we determined the apoptosis-related proteins utilizing 
the Proteome Profiler Array (RayBio® Human Apoptosis 
Antibody Array Kit, Raybiotech, Norcross, GA, USA), in 
accordance with the manufacturer’s instructions. In short, 
the cells were dosed with 20 µg/mL AM. Three hundred µg 
proteins from each sample were incubated overnight with 
the human apoptosis array. The data from the apoptosis 
array were measured by scanning the membrane using a 
Biospectrum AC ChemiHR 40 (UVP, LLC, Upland, CA, 
USA) and examination of the file of the array image was 
conducted using image analysis software in accordance with 
the instructions of the company.
Mammary tumor implantation
Rat LA7 mammary adenocarcinoma cells at around 75%–
85% confluence were trypsinized, washed once in Dulbecco’s 
Modified Eagle’s Medium (supplemented with 5% FBS), 
spun down, and suspended in the same medium. A total of 
two million cells in a volume of 100 µL were injected into the 
mammary fat pads of 20 female Sprague-Dawley rats.
Experimental design and treatment 
of implanted animals
Ten days after implantation of LA7 mammary carcinoma, 
the animals were randomly separated into six groups (n=5 
per group): normal control; mammary tumor control (LA7-
induced non-treated); low dose (treated with 30 mg/kg/day 
of AM dis solved in Tween 20); high dose (treated with 
60 mg/kg/day of AM dissolved in Tween 20); tamoxifen 
(treated subcutaneously with 10 mg/kg/day of tamoxifen 
dissolved in Tween 20); and AM (normal rats treated with 
60 mg/kg/day of AM dissolved in Tween 20). All treatments 
by AM were selected based on the toxicological report by 
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Ibrahim et al,30 and given to the animals orally twice a week 
for 28 days using a gastric tube. At the end of treatment, the 
rats were euthanized and the entire tumor was removed, sec-
tioned, and fixed in 10% paraformaldehyde. All experimental 
procedures performed on animals were done according to 
regulations set by the Institutional Animal Ethical Committee 
(FAR/20/04/2013/MYID), Faculty of Medicine, University 
of Malaya.
Evaluation of effect of AM  
on tumor size
The total tumor volume (mm3) was quantified by multipli-
cation of the slice sections and by summing the segmented 
areas.
Statistical analysis
The results were reported as the mean ± standard deviation for at 
least three analyses for each sample. The normality and homo-
geneity of variance assumptions were checked, and statistical 
analysis was performed according to the SPSS 16.0 package 
(SPSS Inc., Chicago, IL, USA) and GraphPad prism 5.0 
(GraphPad Software, Inc., La Jolla, CA, USA). Analysis of 
variance was performed using the ANOVA procedure.
Results
AM inhibits the growth of MCF-7 cells
The cytotoxic effects of AM on the MCF-7 cells were 
ascertained by means of MTT assay. As shown in Table 1, 
AM inhibited the growth of MCF-7 cells and significant 
inhibition was exhibited at 10.26±0.25 µg/mL after 24 hours. 
Tamoxifen, which was used as standared control, showed 
an IC
50
 of 2.35 µg/mL. Meanwhile, AM did not exhibit any 
cytotoxicity toward the normal breast cell line MCF-10A 
with IC
50
 .30 µg/mL.
AO-PI double staining cell 
morphological analysis
To determine the viable cells, as well as those in early apop-
tosis, late apoptosis and secondary necrosis, the cells were 
counted using a fluorescence microscope. A total of 200 cells 
were counted arbitrarily and differentially, along with the 
negative control, which was untreated. Early apoptosis was 
detected using AO within the fragmented DNA with a bright 
green fluorescence. In addition, the green nuclear structure 
of the control cells was shown to be intact (Figure 1B). 
Following treatment with 5 µg/mL AM, moderate apoptosis 
was observed by blebbing and nuclear chromatin condensa-
tion (Figure 1C). In addition, in the later phases of apopto-
sis, alterations, including a reddish-orange color due to the 
binding of AO to the denatured DNA, were noted after AM 
10 and 20 µg/mL of treatment (Figure 1D and E). The results 
indicated that the AM produced morphological features that 
are linked to apoptosis in a concentration-dependent manner. 
A statistically significant (P,0.05) difference was noted 
in the cell population through the differential recording of 
treated cells (200-cell population) (Figure 1F).
Effect of AM on the ratio of 
apoptotic cells by AV-FITC staining
Flow cytometric analysis, with AV/PI double staining, was 
used to confirm the induced apoptotic effect of AM by deter-
mining the percentage of apoptotic cells. The AV+/PI- staining 
signifies the early apoptotic cells because of the strength of 
the affinity between AV-FITC and phosphatidylserine that 
transported from the inner leaflet to the outer surface of the 
plasma membrane in early apoptosis. In contrast, AV-/PI+ 
staining signifies the necrotic cells, as PI, which cannot 
penetrate an undamaged cell membrane, passes through the 
affected membrane of the dead cells or late apoptotic cells, 
and binds to the nucleic acid. In addition, viable cells are 
marked by AV-/PI-, and AV+/PI+ staining, which is symbolic 
of the late apoptotic cells. The characteristic dot plots of 
the flow cytometric assessment of apoptosis indicated that 
according to the evaluation of the untreated cells (control) and 
treated cells (with 5, 10, and 20 µg/mL AM), the percentages 
in early apoptosis and late apoptosis increased respectively 
(Figure 2). Moreover, the AM treatment clearly resulted in 
slightly fewer viable cells at 5 and 10 µg/mL. In addition, 
the results indicated that the anti-proliferative effect of AM 
in respect of MCF-7 cells was instigated by triggering cell 
apoptosis.
AM-induced apoptosis  
in MCF-7 cells
To verify the occurrence of apoptosis, we inspected the 
alterations in the nuclear morphology of the MCF-7 
cells by determining the nuclear condensation and 
Table 1 IC50 concentrations of AM and tamoxifen
Cell line IC50 ± SD (μg/mL)
AM Tamoxifen
MCF-7 10.26±0.25 2.35±0.35
MCF-10A .30 18.9±0.12
Abbreviations: IC50, half-maximal inhibitory concentration; AM, α-Mangostin; SD, 
standard deviation.
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fragmentation hallmark for apoptosis (Figure 3A). Hoechst 
33342 staining indicated that some of the cells exhibited 
nuclear condensation with 20 µg/mL AM treatment. The 
intensity of the nucleus that directly relates to the apoptotic 
chromatin changes, such as blebbing, fragmentation, and 
condensation, are quantified in Figure 3B. A simultane-
ous increase in the cells’ permeability was also observed 
(Figure 3C).
AM-induced MMP disruption  
and release of cytochrome c
In the apoptosis, MMP is often disturbed by the forming of 
permeability transition pores or the insertion of pro-apop-
totic proteins like Bax or BH3 interacting domain death 
agonist (Bid) in the membrane of mitochondria. Hence, we 
studied the effect of AM on the MMP of MCF-7 cells with 
the use of a mitochondria-specific voltage-dependent dye. 
As displayed in Figure 3D, the MMP in the cells treated 
with AM (P,0.05) showed a considerable reduction. In 
addition to that, a considerable decrease in the intensity 
of fluorescence (Figure 3A), which reflected the break-
down of MMP, AM also activated a major translocation 
of cytochrome c from the mitochondria into the cytosol. 
At 20 µg/mL, AM activated three times the amount of 
cytochrome c released in MCF-7 cells compared to the 
control (P,0.05) (Figure 3E). Moreover, since the release 
of cytochrome c from the mitochondria triggers the activa-
tion of pro-caspace 9, we measured the immunoblotting 
of cytosol cytochrome c. In a concentration-dependent 
manner, AM significantly increased the level of cytosol 
cytochrome c in MCF-7 cells compared to the control 
(P,0.05) (Figure 8D).
Figure 2 The effect of AM on early apoptosis of MCF-7 cells. 
Notes: MCF-7 cells were exposed to different concentrations of AM and incubated for 24 hours at 37°C in a CO2 incubator. After staining with FITC-conjugated Annexin 
V and PI, cells were analyzed by flow cytometry. Control cells received no drug treatments. The early apoptotic events (AV+/PI-) are shown in lower right quadrant (Q4-1) 
of each panel. Quadrant (Q2-1) represents AV+/PI+ late stage of apoptosis/dead cells. (A) The MCF-7 control (n=3). (A–D) The effects of 0, 5, 10, and 20 µg/mL exposures 
(respectively) of MCF-7 cells to AM. 
Abbreviations: AM, α-Mangostin; FITC, fluorescein isothiocyanate; AV, Annexin V; PI, propidium iodide.
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AM regulates the expression  
of Bcl-2 and Bax protein
The expression of pro-apoptotic proteins, such as Bax, is 
an early incident that sensitizes cells to undergo apoptosis. 
Compared with the controls, MCF-7 cells that were treated 
with AM displayed a considerable escalation in fluorescence 
intensity (Figure 4A) when stained using a specific Bax 
antibody. This outcome indicated that the expression of Bax is 
upregulated in MCF-7 cells after  dosing with 20 µg/mL AM. 
Nevertheless, the anti-apoptotic, Bcl-2 levels were minimal 
during the period of treatment (Figure 3A). Figure 3B shows 
that both up and downregulation of Bax and Bcl-2 were sta-
tistically significant (P,0.05) in concentration dependent 
manner. To confirm the immunofluorescence result, the 
expression of Bax and Bcl-2 in the MCF-7 cells treated with 
AM were determined using Western blot analysis. AM treat-
ment resulted in an upregulation of Bax and a downregulation 
of Bcl-2 in concentration dependent manner (Figure 4C), 
which resulted in an increase in the ratio of Bax to Bcl-2, 
therefore favoring apoptosis (Figure 4D).
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Figure 3 Effect of AM on MMP, permeability and cytochrome c release. 
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Effect of AM treatment  
on caspace-3/7, -8, and 9
All the caspace enzymes being examined were shown to be 
induced by the treatment, and were concentration-dependent. 
A high level of caspace 3/7 was found in the greatest 
treatment concentration (20 µg/mL) with a significant 
variance from the control (P,0.05) for both types of cell. 
Although significant levels of caspace-8 and caspace-9 were 
found in both, the triggering of caspace was not found to be 
significantly prompted for caspace 3/7 at 5 and 10 µg/mL. 
Our results provide further validation of the activation of all 
three caspaces by AM in MCF-7 cells (Figure 5A). To con-
firm the immunofluorescence result, the cell extracts were 
obtained after treatments and processed for Western blot 
analysis. The changes in protein levels in the MCF-7 cells 
treated with different concentrations of AM were determined 
using Western blot analysis. In a concentration dependent 
manner, AM treatment resulted in partial cleavage of pro-
caspace-7, -9, and -8 (Figure 5B), which indicated that AM 
could increase the cleavage maturation of caspace-7, -9, 
and -8 (Figure 5C).
Suppression of the PCNA and  
PARP protein expressions by AM
The expression of PCNA and PARP cleavage on MCF-7 
cells with or without AM treatment was tested by Western 
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blot analysis. As shown in Figure 8D and E, after treatment 
with 5, 10, and 20 µg/mL of AM, the level of PCNA protein 
decreased significantly. Since PARP cleavage results in a 
cleaved product of 89 kDa, we have observed the reduc-
tion in the PARP (116 kDa) and concomitant presence of 
a cleaved product in a dose-dependent manner (Figure 8D 
and E).
AM-induced cell death includes 
increased ROS formation
The production of ROS was generally linked to the MMP 
disturbance and cell apoptosis. To determine the relation, 
we inspected the levels of ROS in MCF-7 cells treated with 
AM. ROS was observed by the oxidation-sensitive fluores-
cent dye DCFH-DA. The escalation of dose-dependence 
in DCF fluorescence was observed in the treated cells. 
In addition, a considerable and immediate formation of 
ROS, up to twice as high as observed in the control, was 
identified following the dosing of cells with AM at 10 
and 20 µg/mL (Figure 5D). This result indicated that this 
compound triggered the intracellular ROS development 
of MCF-7 cells.
Cell cycle analysis
We conducted this trial to determine the influence of AM on 
the DNA content of MCF-7 cells by the cell cycle phase dis-
tribution (G
0
, G
1
, S, G
2
, and M) after treatment (Figure 6). The 
results indicated that AM halted the cell cycle progression in 
the G
0
/G
1
 phase (P,0.05). The results displayed in Figure 
6E show that there is a significant G
0
/G
1
 phase arrest in a 
concentration-dependent manner in the MCF-7 cells, which 
accounts for 52.44%, 55.28%, and 68.75% of cells follow-
ing treatment with 5, 10, and 20 µg/mL, respectively, for 
24 hours (P,0.05). Meanwhile, the cells in both the S and 
G
2
/M phases diminished with an increase in the treatment 
concentration.
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Figure 5 Effects of AM on MCF-7 cells’ procaspaces, caspaces, cleaved caspaces, and ROS generation. 
Notes: (A) Relative Iuminescence expression of caspaces in the MCF-7 cells treated with 5 µg/mL, 10 µg/mL, and 20 µg/mL of AM. (B) Western blot analysis of procaspaces 
and cleaved caspaces after treatment with 5 µg/mL, 10 µg/mL, and 20 µg/mL of AM. (C) The blot densities of procaspaces and cleaved caspaces are expressed as folds of control. 
Data are mean ± SD (n=3). *P,0.05 versus control. (D) Relative DCF-fluorescence intensity (ROS) after 5, 10, and 20 µg/mL of AM exposure at 24 hours. Values are mean ± SD 
from three independent experiments. Triplicates of each treatment group were used in each independent experiment. The statistical significance is expressed as *P,0.05.
Abbreviations: AM, α-Mangostin; SD, standard deviation; DCF, 2’,7’-dichlorofluorescin; ROS, reactive oxygen species; OD, optical density.
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Inhibition of TNF-α-induced NF-κB 
nuclear translocation by AM
The obstruction to apoptosis and cell proliferation was con-
sidered to be closely related to the activation of nuclear factor 
kappa-B (NF-κB). Hence, the role of AM in the suppression 
of activated NF-κB induced by the inflammatory cytokine, 
TNF-α, was examined using Alexa Fluor 488-conjugated 
anti-NF-κB antibody (Thermo Fisher Scientific, Waltham, 
MA, USA). Although a high NF-κB fluorescent intensity was 
observed in the cytoplasm in the control cells (medium alone) 
(Figure 7A), it was only faint in the nuclei, which suggests 
an absence of NF-κB activation in the control cells (medium 
alone). In addition, TNF-α alone considerably intensified the 
NF-κB fluorescent intensity in the nuclei. AM demonstrated 
a considerable inhibitory effect on the triggering of NF-κB 
(Figure 7B). In the cells treated with curcumin, a known 
inhibitor of NF-κB activation, a significant suppression of 
TNF-α-induced NF-κB nuclear translocation was observed, 
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as evidenced by the low nuclear NF-κB-related fluorescence 
intensity (Figure 7B). In parallel, the morphological altera-
tions of NF-κB translocation, as shown by the immuno-
fluorescence staining (Figure 7A), indicated the inhibitory 
effect of AM on TNF-α-induced NF-κB translocation in a 
concentration-dependent manner with significant inhibition 
for the 20 µg/mL concentration of AM. To affirm the immu-
nofluorescence result, we measured the immunoblotting of 
the nuclear content of NF-κB p65. As shown in Figure 7C and 
D, treatment with AM significantly decreased the escalation 
of this nuclear protein induced by positive control (TNF-α) 
in a dependent manner, particularly at 20 µg/mL of AM.
Human apoptosis protein array
Following AM exposure for 24 hours, the MCF-7 cells 
were lysed, and the apoptotic markers were screened 
using a protein array (Figures 8 and S1). In Figure 8C, the 
images show representative changes detected. All the major 
markers responsible for the apoptosis signaling pathway, 
including Bax, Bcl-2, Bim, cytochrome c, caspace-3/7 
and -8 were expressed in the two models. A significant 
chaperone Hsp70, which played a part in the apoptosis was 
also downregulated, while the cell proliferation repressor 
protein p27, as well as X-linked inhibitor of apoptosis 
protein (XIAP) were also induced in this in vitro model. 
To confirm the protein array result, the expression of 
Hsp70 in the MCF-7 cells treated with AM was determined 
using Western blot analysis. AM treatment resulted in a 
downregulation of this protein in a concentration dependent 
manner (Figure 8D and E).
AM reduced tumor size in vivo
Table 2 presents the volume and the reduction of tumor 
 percentage (%) of control and experimental animals. 
The tumor growth was measured using a caliper. The 
tumors in the mammary tumor control group grew rapidly, 
reaching an average volume of 1,737±563 mm3 by day 
28. Meanwhile, groups treated with AM 30 mg/kg and 
60 mg/kg showed a significant (P,0.05) reduction in their 
tumor volume when compared with the mammary tumor 
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control group. The AM 60 mg/kg treatment also resulted 
in greater reduction (79.2%) in tumor volume than the AM 
30 mg/kg treatment (74.1%), whilst tamoxifen (10 mg/kg) 
treated groups reduced the mammary tumor by an average 
of 83.6% (Figure 9).
Discussion
The role of apoptosis, which is a highly regulated pro-
cess of programmed cell destruction, is crucial in many 
functions, ranging from fetal development to adult tissue 
homeostasis.31 Tumors are attributed to uncontrolled 
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Figure 8 MCF-7 cells were lysed and protein arrays were performed. 
Notes: Cells were treated with 20 µg/mL AM and the whole cell protein was extracted. Equal amounts of (300 µg) of protein from each sample were used for the assay. 
Representative images of the apoptotic protein array are shown for the control (A) and treatment (B). Quantitative analysis in the arrays showed differences in the apoptotic 
markers (C). Immunoblot analysis of cytosolic cytochrome c, cleaved PARP, PCNA, and Hsp70 (D). The blot densities of cytosolic cytochrome c, PARP, cleaved PARP, PCNA, 
and Hsp70 are expressed as folds of control (E). Data are mean ± SD (n=3). *P,0.05 versus control.
Abbreviations: AM, α-Mangostin; Bax, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma 2; Bid, BH3 interacting domain death agonist; Hsp70, heat shock protein 70; SMAC, 
second mitochondria-derived activator of caspace; XIAP, X-linked inhibitor of apoptosis protein; P27, cyclin-dependent kinase inhibitor 1B; PARP, poly ADP-ribose polymerase; 
SD, standard deviation; PCNA, proliferating cell nuclear antigen; OD, optical density.
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proliferation as well as reduced apoptosis. One critical 
method by which cytotoxic drugs destroy cancer cells 
is the activation of apoptotic pathways.32 Herbal medi-
cines have been a major source from which numerous 
apoptosis-inducing agents are derived,33 and, according 
to several reports, many of these naturally occurring 
compounds may contribute partially to human cancer 
prevention or therapy.34 These studies showed that bioac-
tive compounds elicit apoptosis in cancer cells.35 Renewed 
interest in the application of oriental medicine for cancer 
treatment, along with auspicious clinical results, has 
led to much emphasis being placed on medicinal plants. 
Nevertheless, the chemical components as well as definite 
mechanisms of many herbal medicines remain obscure.
In this regard, C. arborescens is one of the well-known 
plants used in Asian countries for preventing and treating 
different kinds of ailments.14 AM, as a natural compound, 
is a major prenylated xanthone isolated from this plant. 
Therefore, the present study elucidated the mechanism of 
apoptosis provoked by AM toward MCF-7 cells. According 
to Shier,36 compounds that demonstrate an IC
50
 value of more 
than 30 µg/mL are considered as not potentially cytotoxic, 
while compounds with an IC
50
 value of less than 5.0 µg/mL are 
considered very active. These findings show that AM acts dif-
ferently on normal cells compared to cancer cells that are more 
cytotoxic toward mammary gland cancer cells than normal 
cells. Since we found that the cytotoxicity produced by AM is 
within a potential limit, we used AO and PI fluorescent dyes to 
observe the different stages of apoptosis, beginning from the 
condensation of the chromatin up to the formation of apop-
totic bodies, with AM treatment. Although the morphological 
features were clearly noticed, the assay of AV was conducted 
in an attempt to quantify the cells of the apoptotic population. 
The present study established that AM treatment can induce 
cell death in MCF-7 cells through apoptosis. In addition, the 
results showed a significant dose-dependent increase occur-
ring in the early stage of apoptosis.
Although both extrinsic and intrinsic pathways are 
involved in apoptosis, the sensitivity of the intrinsic path-
ways causes tumors to occur more frequently through this 
route.37 Mitochondria are the main cellular components 
for the intrinsic means of apoptosis due to their ability to 
directly initiate the apoptotic cellular program. The primary 
involvement of the mitochondria is in the cell’s redox status, 
although they can also execute multiple cellular functions, 
including energy production, as well as cell proliferation 
and death.38,39 The permeabilization of the outer membrane 
and alteration of the mitochondrial transmembrane poten-
tial (∆ψm) by the mitochondria initiating the apoptotic 
cascade, releases soluble pro-apoptotic proteins including 
cytochrome c, which, ultimately, leads to the activation of 
caspaces 9 and 3.37 It is essential that the potential of the 
mitochondria membrane is decreased for this process to 
begin. The effect of AM on the mitochondria, which causes 
less MMP was revealed by the fluorescence-based high 
content screening analysis. Concurrently, the release of 
cytochrome c also increased. There is much evidence that 
suggests that there is a role of oxidative stress in the apopto-
sis and related mitochondrial changes.40 In order to check the 
involvement of ROS, we measured the ROS level upon AM 
treatment toward MCF-7. The results clearly underline this 
significant relation (P,0.05). There was elevated (3-fold) 
intracellular ROS with AM treatment (20 µg/mL) on MCF-7 
cells and this could be due to the free radical generation 
during the cytotoxicity.
Table 2 Effect of treatment with AM 30 mg/kg, AM 60 mg/kg 
and tamoxifen on tumor volume (mm3) in experimental breast 
cancer in rats
Treatment groups Tumor  
volume (mm3)
Reduction of tumor 
percentage (%)
Normal control – –
Mammary tumor control 1,773±563 –
AM 30 mg/kg LD 460±33.5* 74.1%*
AM 60 mg/kg HD 372±24.6* 79.2%*
Tamoxifen 10 mg/kg 290±21* 83.6%*
AM 60 mg/kg – –
Notes: Each value represents mean ± SD of given number of animals (n=5). The 
statistical significance is expressed as *P,0.05.
Abbreviations: AM, α-Mangostin; LD, low dose; HD, high dose; SD, standard 
deviation.
Figure 9 Therapeutic effect of AM treatment on LA7-induced mammary tumors 
in rats (4 weeks). 
Notes: Reduction of tumor size of rats in treated groups: low dose 30 mg/kg AM 
(B), high dose 60 mg/kg AM (C), and tamoxifen 10 mg/kg (D) compared to the 
mammary tumor control (A).
Abbreviation: AM, α-Mangostin.
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Concurrently, a number of Bcl-2 family members, 
including Bcl-2 and Bax, are known to have the ability to 
control apoptosis.41 In ascertaining the vulnerability of cells 
toward death, it is crucial for a balance to exist between 
anti-apoptotic and pro-apoptotic Bcl-2 family members.42 
It has been shown in previous reports that susceptibility 
to mitochondria mediated apoptosis can be caused by the 
upregulation of Bax and downregulation of Bcl-2.43,44 Thus, 
we examined the effect of AM on the expression of proteins 
that belong to this family. Bcl-2 is a cytoplasmic protein that 
has a significant part in inhibiting apoptosis that is caused 
by factors, such as  chemotherapeutic agents, irradiation, 
as well as the withdrawal of growth factors.45,46 The immu-
nofluorescence results in this research demonstrated the 
Bcl-2 down regulation in MCF-7 cells after treatment with 
20 µg/mL AM. This  occurrence likely explains the apoptotic 
effects of AM on MCF-7 cells. The exertion of these effects 
on the expression of Bcl-2 may also be connected to the 
production of mitochondrial apoptotic factors, which, eventu-
ally, lead to apoptosis.47 Our findings regarding AM support 
previous findings that showed that the induction of apoptosis 
seems to be modulated by the levels of Bcl-2 and Bax in 
the head and neck squamous carcinoma cell line (HNSCC), 
human Caucasian colon adenocarcinoma cell line (COLO 
205), undifferentiated human colon carcinoma cell line 
(MIP-101), and human colon epithelial adenocarcinoma cell 
line (SW 620).21,48
Subsequently, with MMP disruption and the release of 
cytochrome c, AM treatment of MCF-7 cells triggered the 
activation of caspaces 3/7, 8, and 9. In fact, the stimula-
tion of caspaces 9 and 8 happened with a minimum con-
centration of AM, while caspace 3/7 activation only took 
place at a maximum treatment concentration. caspace 9 is 
located in the intermembrane space of the mitochondria. It 
is discharged in a Bcl-2-inhibitable manner following the 
induction of permeability transition, whereas, in cells, the 
release is upon the induction of apoptosis.49 The caspace 9 
that has been released then activates the post-mitochondrial 
caspaces, which include caspaces 3 and 7; the disassembly 
of the cell takes place in what is termed the execution phase 
of apoptosis.50 caspace 8 is closely implicated in apoptosis 
signaling via the extrinsic pathway, albeit it is found in 
the upstream and downstream of the mitochondria.49,51 
Moreover, the engagement of caspace 8 in mitochondrial 
pathways through the cleavage of the Bcl-2 family member 
Bid to tBid has been shown on numerous occasions.52 Our 
results regarding AM are well correlated with a previous 
study on AM against BJMC3879 metastatic murine 
mammary adenocarcinoma cells that showed the activation 
of caspaces 3, 9, and 8.53
PARP can detect DNA damage due to its sensitivity. This 
enzyme is strongly triggered by DNA strand breaks and has 
primary functions in processes, such as DNA repair and the 
maintenance of genome stability. In addition, it also performs 
a crucial role in the induction of cell death initiated by a 
variety of stimuli.54 The proteolytic degradation of PARP 
that takes place at the beginning of apoptosis is caused by the 
activated caspace 3.55 As demonstrated by the immunoblot 
analysis, AM treatment significantly reduced PARP. Based on 
the results, it was shown that the stimulation of caspaces-9 
and -3 is induced by the released cytochrome c, which, in 
turn, cleaves 116 kDa PARP into 85 kDa fragments in MCF-7 
treated cells. PARP plays a crucial role in DNA repair and 
interacts with many DNA replication/repair factors, including 
the PCNA, a protein involved in many DNA transactions.56 
Our next aim was to detect the response of AM toward this 
interaction. The anti-proliferative efficacy of AM has been 
established as it was found to decrease the immunoblotting 
expression of this proliferative marker in MCF-7 cells.
The mode of apoptosis caused by numerous natural com-
pounds is closely related to cell cycle arrest.57–59 It has been 
established that cell cycle control is a significant event in 
safe-guarding precise cellular division. Many carcinogenic 
processes are reported to cause the abnormalities of cell 
cycle regulators. For this reason, it is reasonable to target 
and alter the cell cycle regulators in cancer cells for the 
purpose of chemoprevention and treatment.60–62 Following 
dosage with various concentrations of AM, the examination 
of the cell cycle of MCF-7 cells exhibited a higher number of 
cells in the G
0
/G
1
 phase. On the other hand, the amount of 
cells in the S and G
2
/M phase was reduced in comparison 
with the untreated cells (Figure 6). These results indicate the 
ability of AM in inhibiting cellular proliferation via G
0
/G
1
 
phase arrest. This corroborates a previous study concerning 
the effect of AM against BJMC3879 cells, which demon-
strated the inhibition of cellular proliferation via G
0
/G
1
 
phase arrest.53
The nuclear factor kappa-light-chain-enhancer of acti-
vated B cells, also known as NF-κB, is a protein complex that 
plays a role in regulating DNA transcription. In addition, it 
has also been considered as an apoptosis inhibitor.63,64 Thus, 
repression of the NF-κB activity can induce apoptosis. In 
this study, we have demonstrated that AM can prevent the 
TNF-α-induced NF-κB translocation of the cytoplasm to the 
nucleus of the MCF-7 cells, suggesting the participation of 
an NF-κB inhibition mechanism in apoptosis.
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Apoptosis involves a large number of proteins.65,66 To 
determine the role of the central apoptosis-related proteins, 
a protein array analysis was conducted. In this study, various 
proteins in the extrinsic and intrinsic pathways were examined. 
These proteins include those that are known to cause apop-
tosis, including Bax, caspace-3, cytochrome c, caspace-8, 
and second mitochondria-derived activator of caspace, as 
well as those that have been recognized as anti-apoptotic, 
including Bcl-2, XIAP, of which XIAP is a member of the 
inhibitors of apoptosis (IAP) family of proteins,67 and second 
mitochondria-derived activator of caspace is a pro-apoptosis 
protein that acts together with IAP to reduce their inhibitory 
effects.68,69 Together with the Bcl-2 family members, Hsps 
have also been deemed to be apoptosis inhibitors, due to 
their significant role in cell survival, through stopping the 
release of cytochrome c from mitochondria or by preventing 
the formation of apoptosome.70 The protein array analysis 
showed a significant reduction in Hsp70 following treatment 
with AM. This finding is consistent with the findings from an 
earlier study71,72 that indicated that apoptosis could be sup-
pressed by an over-expression of Hsp70.71,72 The results from 
the protein array displayed a characteristic profile of protein 
levels related to the mitochondrial apoptosis in MCF-7 cells 
treated with AM.
In the second part of this study, we also evaluated the 
effect of AM on tumor growth in Sprague-Dawley rats 
induced with LA7 cells to develop breast cancer for a duration 
of 28 days. The AM-treated groups (30 mg/kg and 60 mg/kg) 
showed significant tumor size reduction compared with the 
mammary cancer untreated group, indicating the potential 
chemotherapeutic value of AM in vivo. Our results regarding 
AM are well correlated with a previous study on AM against 
BJMC3879 metastatic murine mammary adenocarcinoma 
cells that showed the reduction of tumors after treatment 
with AM.53
According to the observations mentioned in this report, 
it can be concluded that AM has the ability to induce apop-
tosis in MCF-7 cells with cell death-transducing signals that 
regulate the MMP through a downregulation of Bcl2 and an 
upregulation of Bax, which, in turn, triggers the release of 
the cytochrome c from mitochondria to cytosol. The acti-
vation of caspace-9 is triggered once cytochrome c enters 
the cytosol, followed by the activation of the downstream 
executioner caspace-3/7. Subsequently, it cleaves specific 
substrates, making way for the occurrence of apoptotic 
changes. An increase of caspace-8 has shown the involvement 
of extrinsic pathways. This form of apoptosis was suggested 
to occur through both the extrinsic- and intrinsic-apoptosis 
pathways with regulation of NF-κB, Bax/Bcl-2, and Hsp70 
protein modulation. In addition to that, ingestion of AM 
at (30 or 60 mg/kg) significantly reduced tumor size in an 
animal model of breast cancer.
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α-Mangostin demonstrates apoptogenesis in MCF-7 cells
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Figure S1 MCF-7 cells were lysed and protein arrays were performed. 
Notes: Cells were treated with 20 µg/mL AM and the whole cell protein was extracted. Equal amounts of (300 µg) of protein from each sample were used for the assay 
(A and B). 
Abbreviations: BAD, Bcl-2-associated death promoter; Bcl-w, Bcl-2-like protein 2; IGF-II, insulin-like growth factor 2; IGF-I, insulin-like growth factor 1; HTRA, high 
temperature requirement A; Hsp70, heat shock protein 70; Hsp27, heat shock protein 27; FasL, Fas ligand protein; Fas, Fas receptor protein; DR6, death receptor 6; IGFBP, 
insulin-like growth factor binding protein; Livin, melanoma/kidney inhibitor of apoptosis protein; p21, cyclin-dependent kinase; p53, tumor suppressor p53; TNF-α, tumor 
necrosis factor alpha; AM, α-Mangostin.
Supplementary materials
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